Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $697,773 | $890,799 | $1,004,178 |
| - Cash | $170,084 | $299,322 | $273,571 | $222,947 |
| + Debt | $91,215 | $93,405 | $96,095 | $97,891 |
| Enterprise Value | – | $491,856 | $713,323 | $879,122 |
| Revenue | $240 | $1,214 | $3,032 | $12,374 |
| % Growth | -80.2% | -60% | -75.5% | – |
| Gross Profit | -$151,212 | -$96,306 | -$114,583 | -$76,415 |
| % Margin | -63,005% | -7,932.9% | -3,779.1% | -617.5% |
| EBITDA | -$159,975 | -$115,672 | -$135,660 | -$100,230 |
| % Margin | -66,656.3% | -9,528.2% | -4,474.3% | -810% |
| Net Income | -$163,141 | -$110,958 | -$120,965 | -$104,589 |
| % Margin | -67,975.4% | -9,139.9% | -3,989.6% | -845.2% |
| EPS Diluted | -1.17 | -0.8 | -0.88 | -0.76 |
| % Growth | -46.2% | 9.1% | -15.8% | – |
| Operating Cash Flow | -$167,570 | -$120,219 | -$78,116 | -$87,635 |
| Capital Expenditures | -$317 | -$2,538 | -$1,629 | -$2,407 |
| Free Cash Flow | -$167,887 | -$122,757 | -$79,745 | -$90,042 |